- Home
- NKTX vs CRNT Comparison
NKTX vs CRNT Comparison
Compare NKTX & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- CRNT
- Stock Information
- Founded
- NKTX 2015
- CRNT 1996
- Country
- NKTX United States
- CRNT Israel
- Employees
- NKTX N/A
- CRNT N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- CRNT Radio And Television Broadcasting And Communications Equipment
- Sector
- NKTX Health Care
- CRNT Technology
- Exchange
- NKTX Nasdaq
- CRNT Nasdaq
- Market Cap
- NKTX 225.1M
- CRNT 207.3M
- IPO Year
- NKTX 2020
- CRNT 2000
- Fundamental
- Price
- NKTX $2.45
- CRNT $3.70
- Analyst Decision
- NKTX Strong Buy
- CRNT Strong Buy
- Analyst Count
- NKTX 5
- CRNT 2
- Target Price
- NKTX $17.00
- CRNT $4.88
- AVG Volume (30 Days)
- NKTX 1.2M
- CRNT 952.0K
- Earning Date
- NKTX 11-07-2024
- CRNT 11-13-2024
- Dividend Yield
- NKTX N/A
- CRNT N/A
- EPS Growth
- NKTX N/A
- CRNT N/A
- EPS
- NKTX N/A
- CRNT 0.21
- Revenue
- NKTX N/A
- CRNT $377,617,000.00
- Revenue This Year
- NKTX N/A
- CRNT $15.30
- Revenue Next Year
- NKTX N/A
- CRNT $6.42
- P/E Ratio
- NKTX N/A
- CRNT $17.46
- Revenue Growth
- NKTX N/A
- CRNT 13.62
- 52 Week Low
- NKTX $2.38
- CRNT $1.75
- 52 Week High
- NKTX $16.24
- CRNT $3.71
- Technical
- Relative Strength Index (RSI)
- NKTX 26.80
- CRNT 84.28
- Support Level
- NKTX $2.40
- CRNT $2.65
- Resistance Level
- NKTX $3.81
- CRNT $3.18
- Average True Range (ATR)
- NKTX 0.25
- CRNT 0.21
- MACD
- NKTX -0.02
- CRNT 0.11
- Stochastic Oscillator
- NKTX 4.90
- CRNT 99.28
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.